A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

被引：0
|
作者：
Mark E Robson
Pierre O Chappuis
Jaya Satagopan
Nora Wong
Jeff Boyd
John R Goffin
Clifford Hudis
David Roberge
Larry Norton
Louis R Bégin
Kenneth Offit
William D Foulkes
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Medicine
[2] Cancer Prevention Centre,Research Institute of McGill University Health Centre
[3] McGill University,Department of Epidemiology/Biostatistics
[4] Memorial Sloan-Kettering Cancer Center,Cancer Prevention Centre, Sir Mortimer B Davis
[5] McGill University,Jewish General Hospital
[6] Memorial Sloan-Kettering Cancer Center,Department of Surgery
[7] McGill University,Department of Oncology
[8] McGill University,Department of Pathology
[9] McGill University,Program in Cancer Genetics, Departments of Oncology and Human Genetics
[10] University Hospitals of Geneva,Divisions of Oncology and Medical Genetics
[11] Hôpital du Sacré-Coeur de Montréal,Division of Hematology/Oncology, Department of Medicine
[12] Tufts University,undefined
[13] Tufts University-New England Medical Center,undefined
来源：
Breast Cancer Research | / 6卷
关键词：
adjuvant therapy; breast cancer; contralateral; ipsilateral; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A combined analysis of outcome following breast cancer:: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
    Robson, ME
    Chappuis, PO
    Satagopan, J
    Wong, N
    Boyd, J
    Goffin, JR
    Hudis, C
    Roberge, D
    Norton, L
    Bégin, LR
    Offit, K
    Foulkes, WD
    BREAST CANCER RESEARCH, 2004, 6 (01): : R8 - R17
  • [2] Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
    Friedman, LS
    Gayther, SA
    Kurosaki, T
    Gordon, D
    Noble, B
    Casey, G
    Ponder, BAJ
    AntonCulver, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (02) : 313 - 319
  • [3] BRCA1 and BRCA2 mutation analysis in Irish breast cancer families
    McDevitt, T
    Miller, N
    Ormiston, W
    Cody, N
    Daly, PA
    McDermott, E
    Carney, DE
    Green, AJ
    Barton, DE
    AlKindi, S
    O'Malley, K
    Nolan, C
    JOURNAL OF MEDICAL GENETICS, 2000, 37 : S35 - S35
  • [4] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [5] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [6] Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: impact of adjuvant systemic treatment
    Hooning, M.
    Jager, A.
    Koppert, L.
    Van Deurzen, C.
    Collee, M.
    Hollestelle, A.
    Seynaeve, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S140 - S140
  • [7] Risk of second non breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving treatment
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 127 - 128
  • [8] Prognosis of BRCA1 and BRCA2 mutation carriers with breast cancer
    Rennert, G
    Bisland-Becktell, S
    Almog, R
    Zhang, S
    Rennert, HS
    Narod, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (02) : 221 - 221
  • [9] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K
    Lynch, HT
    Chadirian, P
    Tung, N
    Olivotto, V
    Warner, E
    Olopade, OI
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Foulkes, WD
    Narod, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2328 - 2335
  • [10] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
12345